James Christopher Barry - 28 Mar 2022 Form 4 Insider Report for NUVASIVE INC

Role: Chief Executive Officer, Director
Signature: /s/ Nathaniel B. Sisitsky, Attorney-in-fact for James Christopher Barry
Issuer symbol: N/A
Transactions as of: 28 Mar 2022
Net transactions value: -$275,000
Form type: 4
Filing time: 30 Mar 2022, 17:50:57 UTC
Previous filing: 03 Mar 2022
Next filing: 15 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUVA	Common Stock	Sale	$275,000	-5,000	-8.3%	$55.00	55,218	28 Mar 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
F2	Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.